70 related articles for article (PubMed ID: 15807457)
1. [Cytokine spectrum in patients with chronic hepatitis C in the treatment with interferon-alpha drugs].
Sobchak DM; Korochkina OV; Monakova EA
Ter Arkh; 2005; 77(2):70-2. PubMed ID: 15807457
[TBL] [Abstract][Full Text] [Related]
2. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
McHutchison JG; Shiffman ML; Cheung RC; Gordon SC; Wright TL; Pottage JC; McNair L; Ette E; Moseley S; Alam J
Antivir Ther; 2005; 10(5):635-43. PubMed ID: 16152757
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment.
Malaguarnera M; Di Fazio I; Laurino A; Ferlito L; Romano M; Trovato BA
Int J Clin Pharmacol Ther; 1997 Sep; 35(9):385-8. PubMed ID: 9314092
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.
Dai CY; Chuang WL; Chang WY; Chen SC; Lee LP; Hsieh MY; Hou NJ; Lin ZY; Hsieh MY; Wang LY; Yu ML
Antiviral Res; 2005 Aug; 67(2):93-7. PubMed ID: 16051377
[TBL] [Abstract][Full Text] [Related]
7. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.
Pham TN; Mercer SE; Michalak TI
J Viral Hepat; 2009 Aug; 16(8):547-56. PubMed ID: 19215578
[TBL] [Abstract][Full Text] [Related]
9. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment.
Yamaji K; Nabeshima S; Murata M; Chong Y; Furusyo N; Ikematsu H; Hayashi J
Cancer Immunol Immunother; 2006 Apr; 55(4):394-403. PubMed ID: 16041541
[TBL] [Abstract][Full Text] [Related]
11. [Anti-virus response and interferon, cytokine systems in patients with chronic hepatitis C].
Makashova VV; Florianu AI
Ter Arkh; 2008; 80(11):7-10. PubMed ID: 19143182
[TBL] [Abstract][Full Text] [Related]
12. Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.
Zografos TA; Rigopoulou EI; Liaskos C; Togousidis E; Zachou K; Gatselis N; Germenis A; Dalekos GN
J Hepatol; 2006 May; 44(5):848-55. PubMed ID: 16530290
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
14. The levels of IL-1 nu beta, IL-2, IL-4, IL-6 and IFN-gamma among patients with chronic hepatitis type C treated with IFN-alpha.
Łapiński TW
Rocz Akad Med Bialymst; 2000; 45():211-27. PubMed ID: 11712433
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of interferon gamma for chronic hepatitis C.
Soza A; Heller T; Ghany M; Lutchman G; Jake Liang T; Germain J; Hsu HH; Park Y; Hoofnagle JH
J Hepatol; 2005 Jul; 43(1):67-71. PubMed ID: 15913831
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of the values of immune response mediators in patients with acute hepatitis C receiving combined antiviral therapy].
Sobchak DM; Korochkina OV; Sobolevskaia OL
Klin Med (Mosk); 2006; 84(12):47-50. PubMed ID: 17294884
[TBL] [Abstract][Full Text] [Related]
17. [Immune system reactivity in patients with chronic hepatitis c].
Sobchak DM; Korochkina OV
Ter Arkh; 2008; 80(2):61-6. PubMed ID: 18372599
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of natural BALL-1 interferon-alpha treatment for patients with chronic hepatitis C and a possible enhancing effect of a twice-daily starting regimen with interferon-beta.
Ebinuma H; Saito H; Tada S; Nakamoto N; Kurita S; Kitamaura K; Horikawa H; Kumagai N; Tsuchimoto K; Ishii H; Hibi T;
Hepatogastroenterology; 2006; 53(67):94-9. PubMed ID: 16506384
[TBL] [Abstract][Full Text] [Related]
19. Expression of IFN-gamma and its receptor alpha in the peripheral blood of patients with chronic hepatitis C.
Zhang P; Chen Z; Chen F; Li MW; Fan J; Zhou HM; Liu JH; Huang Z
Chin Med J (Engl); 2004 Jan; 117(1):79-82. PubMed ID: 14733779
[TBL] [Abstract][Full Text] [Related]
20. [Serum intercellular adhesion molecule ICAM-1 concentration in interferon alpha treated patients with chronic viral C hepatitis].
Warakomska I; Wiczkowski A; Kepa L; Stolarz W; Wilczek K; Błedowski D; Sobala-Szczygieł B; Oczko-Grzesik B; Dziambor AP; Mossor K
Wiad Lek; 2004; 57(11-12):641-6. PubMed ID: 15865242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
